Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Damia · SciRah

Researcher profile · Semantic Scholar

G. Damia

Share profile

G. Damia — researcher profile on SciRah

h-index: 41
Works: 185
Citations: 5,559

Most-cited papers

Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition
L. Ferguson, Helen Y. Chen, A. Collins, Marisa Connell +31 more
2015Seminars in Cancer Biology309 citations Open access
Semantic Scholar
Platinum Resistance in Ovarian Cancer: Role of DNA Repair
G. Damia, M. Broggini
2019Cancers276 citations Open access
Semantic Scholar
A Broad-Spectrum Integrative Design for Cancer Prevention and Therapy
K. Block, C. Gyllenhaal, Leroy Lowe, A. Amedei +176 more
2015Seminars in Cancer Biology249 citations Open access
Semantic Scholar
DNA damage response inhibitors: Mechanisms and potential applications in cancer therapy.
L. Carrassa, G. Damia
2017Cancer Treatment Reviews153 citations
Semantic Scholar
Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations.
F. Ricci, Francesca Bizzaro, M. Cesca, F. Guffanti +12 more
2014Cancer Research119 citations Open access
Semantic Scholar
Present and Future Perspective on PLK1 Inhibition in Cancer Treatment
M. Chiappa, Serena Petrella, G. Damia, M. Broggini +2 more
2022Frontiers in Oncology103 citations Open access
Semantic Scholar
Overcoming PARPi resistance: Preclinical and clinical evidence in ovarian cancer.
M. Chiappa, F. Guffanti, F. Bertoni, I. Colombo +1 more
2021Drug resistance updates103 citations
Semantic Scholar
Recent Insights into Mucinous Ovarian Carcinoma
F. Ricci, R. Affatato, L. Carrassa, G. Damia
2018International Journal of Molecular Sciences66 citations Open access
Semantic Scholar
Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma
Rosaria Chilà, A. Basana, M. Lupi, F. Guffanti +8 more
2014OncoTarget62 citations Open access
Semantic Scholar
Targeting DNA-PK in cancer.
G. Damia
2020Mutation research61 citations
Semantic Scholar
Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism.
Marie Angèle Cucci, Margherita Grattarola, C. Dianzani, G. Damia +5 more
2020Free Radical Biology & Medicine57 citations Open access
Semantic Scholar
Role and therapeutic potential of CDK12 in human cancers.
Rosaria Chilà, F. Guffanti, G. Damia
2016Cancer Treatment Reviews52 citations
Semantic Scholar
VEGF pathway inhibition potentiates PARP inhibitor efficacy in ovarian cancer independent of BRCA status
Francesca Bizzaro, Ilaria Fuso Nerini, Molly A. Taylor, A. Anastasia +18 more
2021Journal of Hematology & Oncology48 citations Open access
Semantic Scholar
The pharmacological point of view of resistance to therapy in tumors.
G. Damia, S. Garattini
2014Cancer Treatment Reviews48 citations
Semantic Scholar
Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts
F. Ricci, L. Brunelli, R. Affatato, Rosaria Chilà +7 more
2019Therapeutic Advances in Medical Oncology44 citations Open access
Semantic Scholar
New class of squalene-based releasable nanoassemblies of paclitaxel, podophyllotoxin, camptothecin and epothilone A.
Stella Borrelli, Michael S. Christodoulou, Ilaria Ficarra, A. Silvani +7 more
2014European journal of medicinal chemistry42 citations Open access
Semantic Scholar
Current HRD assays in ovarian cancer: differences, pitfalls, limitations, and novel approaches
F. Guffanti, Ilaria Mengoli, G. Damia
2024Frontiers in Oncology36 citations Open access
Semantic Scholar
Identification of PLK1 as a New Therapeutic Target in Mucinous Ovarian Carcinoma
R. Affatato, L. Carrassa, Rosaria Chilà, M. Lupi +2 more
2020Cancers34 citations Open access
Semantic Scholar
Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts
F. Guffanti, M. Alvisi, A. Anastasia, F. Ricci +11 more
2021British Journal of Cancer33 citations Open access
Semantic Scholar
4-(1,2-diarylbut-1-en-1-yl)isobutyranilide derivatives as inhibitors of topoisomerase II.
Michael S. Christodoulou, M. Zarate, F. Ricci, G. Damia +7 more
2016European journal of medicinal chemistry33 citations Open access
Semantic Scholar
Bcl-2 family inhibitors sensitize human cancer models to therapy
Elisabetta Valentini, M. Di Martile, Matteo Brignone, Marica Di Caprio +17 more
2023Cell Death and Disease32 citations Open access
Semantic Scholar
Benzylidenetetralones, cyclic chalcone analogues, induce cell cycle arrest and apoptosis in HCT116 colorectal cancer cells
Dávid Drutovič, M. Chripková, M. Pilátová, P. Kruzliak +6 more
2014Tumor Biology32 citations
Semantic Scholar
Can the response to a platinum-based therapy be predicted by the DNA repair status in non-small cell lung cancer?
M. Macerelli, M. Ganzinelli, C. Gouédard, M. Broggini +4 more
2016Cancer Treatment Reviews31 citations
Semantic Scholar
Characterization of MTAP Gene Expression in Breast Cancer Patients and Cell Lines
S. F. V. de Oliveira, M. Ganzinelli, Rosaria Chilà, L. Serino +8 more
2016PLoS ONE30 citations Open access
Semantic Scholar
Resistance to glucose starvation as metabolic trait of platinum-resistant human epithelial ovarian cancer cells
Anna Pastò, Anna Pagotto, G. Pilotto, A. De Paoli +8 more
2016OncoTarget29 citations Open access
Semantic Scholar
Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy
F. Ricci, M. Fratelli, F. Guffanti, L. Porcu +4 more
2016OncoTarget28 citations Open access
Semantic Scholar
DNA Damage Response Inhibitor Combinations Exert Synergistic Antitumor Activity in Aggressive B-Cell Lymphomas
Valentina Restelli, M. Lupi, Rosaria Chilà, M. Vagni +6 more
2019Molecular Cancer Therapeutics26 citations
Semantic Scholar
Targeting the DNA damage response for patients with lymphoma: Preclinical and clinical evidences.
L. Carrassa, I. Colombo, G. Damia, F. Bertoni
2020Cancer Treatment Reviews25 citations Open access
Semantic Scholar
In Vitro and In Vivo Activity of Lucitanib in FGFR1/2 Amplified or Mutated Cancer Models
F. Guffanti, Rosaria Chilà, E. Bello, M. Zucchetti +8 more
2016Neoplasia24 citations Open access
Semantic Scholar
Study of the antilymphoma activity of pracinostat reveals different sensitivities of DLBCL cells to HDAC inhibitors.
A. Mensah, F. Spriano, G. Sartori, V. Priebe +12 more
2021Blood Advances23 citations Open access
Semantic Scholar
Combinations of ATR, Chk1 and Wee1 Inhibitors with Olaparib Are Active in Olaparib Resistant Brca1 Proficient and Deficient Murine Ovarian Cells
M. Chiappa, F. Guffanti, Martina Anselmi, M. Lupi +3 more
2022Cancers22 citations Open access
Semantic Scholar
Characterization of a mantle cell lymphoma cell line resistant to the Chk1 inhibitor PF-00477736
Valentina Restelli, Rosaria Chilà, M. Lupi, A. Rinaldi +4 more
2015OncoTarget21 citations Open access
Semantic Scholar
Inhibition of CHK1 and WEE1 as a new therapeutic approach in diffuse large B cell lymphomas with MYC deregulation
Valentina Restelli, M. Vagni, A. Arribas, F. Bertoni +2 more
2018British Journal of Haematology20 citations
Semantic Scholar
The Landscape of PARP Inhibitors in Solid Cancers
Marta Muzzana, M. Broggini, G. Damia
2025OncoTargets and Therapy18 citations Open access
Semantic Scholar
Onvansertib treatment overcomes olaparib resistance in high-grade ovarian carcinomas
M. Chiappa, A. Decio, L. Guarrera, Ilaria Mengoli +18 more
2024Cell Death and Disease18 citations Open access
Semantic Scholar
Impact of the interplay between stemness features, p53 and pol iota on replication pathway choices
M. Ihle, S. Biber, I. Schroeder, C. Blattner +4 more
2021Nucleic Acids Research18 citations Open access
Semantic Scholar
Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts
F. Guffanti, M. Fratelli, M. Ganzinelli, M. Bolis +11 more
2018OncoTarget18 citations Open access
Semantic Scholar
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis
L. Zanotti, C. Romani, L. Tassone, P. Todeschini +15 more
2017BMC Cancer18 citations Open access
Semantic Scholar
Click Reaction as a Tool to Combine Pharmacophores: The Case of Vismodegib.
Michael S. Christodoulou, M. Mori, R. Pantano, Romina Alfonsi +8 more
2015ChemPlusChem18 citations Open access
Semantic Scholar
The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib
G. Sartori, C. Tarantelli, F. Spriano, E. Gaudio +14 more
2023bioRxiv17 citations Open access
Semantic Scholar
Combination of paclitaxel, bevacizumab and MEK162 in second line treatment in platinum-relapsing patient derived ovarian cancer xenografts
F. Ricci, F. Guffanti, G. Damia, M. Broggini
2017Molecular Cancer17 citations Open access
Semantic Scholar
Heteronanoparticles by self-Assembly of Doxorubicin and Cyclopamine Conjugates.
G. Fumagalli, B. Stella, I. Pastushenko, F. Ricci +9 more
2017ACS Medicinal Chemistry Letters16 citations Open access
Semantic Scholar
Cyclopamine-Paclitaxel-Containing Nanoparticles: Internalization in Cells Detected by Confocal and Super-Resolution Microscopy.
G. Fumagalli, D. Mazza, Michael S. Christodoulou, G. Damia +6 more
2015ChemPlusChem16 citations Open access
Semantic Scholar
The disruption of the CCDC6 – PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma
F. Morra, F. Merolla, G. Damia, F. Ricci +9 more
2022Journal of experimental & clinical cancer research : CR14 citations Open access
Semantic Scholar
Exploiting endocytosis for transfection of mRNA for cytoplasmatic delivery using cationic gold nanoparticles
Muriel F. Gustà, M. Edel, Vivian A Salazar, B. Álvarez-Palomo +10 more
2023Frontiers in Immunology13 citations Open access
Semantic Scholar
The impact of DNA damage response gene polymorphisms on therapeutic outcomes in late stage ovarian cancer
F. Guffanti, R. Fruscio, Eliana Rulli, G. Damia
2016Scientific Reports13 citations Open access
Semantic Scholar
An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma
F. Reggiani, E. Sauta, F. Torricelli, E. Zanetti +8 more
2021Molecular Cancer11 citations Open access
Semantic Scholar
Establishment of patient-derived tumor xenograft models of mucinous ovarian cancer.
F. Ricci, F. Guffanti, R. Affatato, L. Brunelli +9 more
2020American Journal of Cancer Research11 citations
Semantic Scholar
Multi-Chemotherapeutic Schedules Containing the pan-FGFR Inhibitor ARQ 087 are Safe and Show Antitumor Activity in Different Xenograft Models
Rosaria Chilà, Terence Hall G., G. Abbadessa, M. Broggini +1 more
2017Translational Oncology11 citations Open access
Semantic Scholar
Overview of BH3 mimetics in ovarian cancer.
D. Del Bufalo, G. Damia
2024Cancer Treatment Reviews10 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Ricci×18
Invite
F. Ricci — researcher profile on SciRah
F. Guffanti×16
Invite
F. Guffanti — researcher profile on SciRah
Rosaria Chilà×10
Invite
Rosaria Chilà — researcher profile on SciRah
R. Fruscio×9
Invite
R. Fruscio — researcher profile on SciRah

×9

Invite

F. Bertoni — researcher profile on SciRah

Invite

M. Broggini — researcher profile on SciRah

Invite

L. Carrassa — researcher profile on SciRah

Invite

M. Lupi — researcher profile on SciRah

Invite

M. Chiappa — researcher profile on SciRah

Valentina Restelli×5

Invite

Valentina Restelli — researcher profile on SciRah

Michael S. Christodoulou×5

Invite

Michael S. Christodoulou — researcher profile on SciRah

D. Passarella×5

Invite

D. Passarella — researcher profile on SciRah